Publication Name	World Journal of Clinical Cases
Manuscript ID	97614
Country	China

Received	2024-06-04 08:26
Peer-Review Started	2024-06-04 08:26
To Make the First Decision
Return for Revision	2024-09-06 01:24
Revised	2024-09-17 16:20
Second Decision	2024-09-23 02:40
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2024-09-23 10:58
Articles in Press	2024-09-23 10:58
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2024-09-25 03:01
Publish the Manuscript Online	2024-09-27 08:43

ISSN	2307-8960 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Otorhinolaryngology
Manuscript Type	Editorial
Article Title	Early screening to identify and diagnose primary nasal tuberculosis in patients with tumor necrosis factor inhibitors
Manuscript Source	Invited Manuscript
All Author List	Dan-Xiang Shen, Yu-Wei Wang, Zhi-Min Lin, Di Jin, Zhen-Hua Ying and Chen Li
ORCID	Author(s) ORCID Number Zhen-Hua Ying http://orcid.org/0000-0002-5443-3675 Chen Li http://orcid.org/0000-0002-8527-1680
Funding Agency and Grant Number
Corresponding Author	Chen Li, MD, Chief Doctor, Doctor, Doctor, Staff Physician, Department of Rheumatology, Fangshan Hospital, Beijing University of Chinese Medicine, No. 151 Chengguan South Street, Fangshan District, Beijing 102400, China. casio1981@163.com
Key Words	Tumor necrosis factor inhibitor; Interferon-gamma release assay; Primary nasal tuberculosis; Rhinoscopy; Diabetes mellitus
Core Tip	Patients receiving tumor necrosis factor inhibitor therapy rarely develop primary nasal tuberculosis, with diabetes, human immunodeficiency virus, and minimally invasive nasal surgery being risk factors. Early nasal endoscopy and an appropriately increased frequency of interferon gamma release assay testing may aid in the early screening and identification of nasal tuberculosis.
Publish Date	2024-09-27 08:43
Citation	<p>Shen DX, Wang YW, Lin ZM, Jin D, Ying ZH, Li C. Early screening to identify and diagnose primary nasal tuberculosis in patients with tumor necrosis factor inhibitors. <i>World J Clin Cases</i> 2024; 12(33): 6604-6607</p>
URL	https://www.wjgnet.com/2307-8960/full/v12/i33/6604.htm
DOI	https://dx.doi.org/10.12998/wjcc.v12.i33.6604

Full Article (PDF)	WJCC-12-6604-with-cover.pdf
Manuscript File	97614_Auto_Edited_033837.docx
Answering Reviewers	97614-answering-reviewers.pdf
Audio Core Tip	97614-audio.wav
Conflict-of-Interest Disclosure Form	97614-conflict-of-interest-statement.pdf
Copyright License Agreement	97614-copyright-assignment.pdf
Non-Native Speakers of English Editing Certificate	97614-non-native-speakers.pdf
Peer-review Report	97614-peer-reviews.pdf
Scientific Misconduct Check	97614-scientific-misconduct-check.png
Scientific Editor Work List	97614-scientific-editor-work-list.pdf
CrossCheck Report	97614-crosscheck-report.pdf
CrossCheck Report	97614-crosscheck-report.png